Brief: Anges Halting Development Of Coronavirus Vaccine For Earlier Variant, Starting For Omicron Ba-5 Variant
07/09/2022 08:08
Sept 7 (Reuters) - AnGes Inc 4563.T :
* ANGES: HALTING DEVELOPMENT OF CORONAVIRUS VACCINE FOR
EARLIER
VARIANT, STARTING FOR OMICRON BA-5 VARIANT
Source text for Eikon: ID:
Further company coverage: 4563.T
(Reporting by Satoshi Sugiyama)
((Satoshi.Sugiyama@thomsonreuters.com;))
Recent news on AnGes
See all newsTable: Anges -Q1 group results
Brief: Vasomune Therapeutics, Inc., And Anges, Inc., Announce Us FDA Clearance Of Investigational New Drug (Ind) Application For Pegevongitide (Av-001) Treatment In Resuscitation Of Severely Burned Patients
Table: Anges -2025 parent results
Table: Anges -2025 group results
Brief: Anges & Vasomune Therapeutics Enter Agreement For AV-001